USE OF SPERMIDINE TO RELIEVE INHIBITION OF LIGASE USE OF SPERMIDINE TO RELIEVE INHIBITION OF LIGASE CHAIN REACTION IN A CLINICAL TEST SAMPLE CHAIN REACTION IN A CLINICAL TEST SAMPLE

Title:

USE OF SPERMIDINE TO RELIEVE INHIBITION OF LIGASE USE OF SPERMIDINE TO RELIEVE INHIBITION OF LIGASE CHAIN REACTION IN A CLINICAL TEST SAMPLE CHAIN REACTION IN A CLINICAL TEST SAMPLE

Document Type and Number:

WIPO Patent Application WO1996012824

Kind Code:

A3

More Like This:

WO/2005/049639	COMPOSITIONS AND METHODS FOR PROTEIN ISOLATION
JP2002511265	[Title of Invention] A novel human transcription factor-based glaucoma therapeutic agent and diagnostic agent.
WO/1999/025828	A HUMAN 2-19 PROTEIN HOMOLOGUE, Z219C

Inventors:

DAVIS ALAN H
CAO JIANLI
LEE EUI H

Application Number:

PCT/US1995/012874

Publication Date:

June 27, 1996

Filing Date:

October 18, 1995

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ABBOTT LAB (US)

International Classes:

C12Q1/68; (IPC1-7): C12Q1/68; C12P19/34

Domestic Patent References:

WO1991017239A1

1991-11-14

Foreign References:

EP0320308A2

1989-06-14

Other References:

DATABASE WPI Week 9444, Derwent World Patents Index; AN 94-353745, XP002001116, "nucleic acid amplify presence poly amine efficiency remove inhibit cause impure biological sample"
DATABASE WPI Week 8712, Derwent World Patents Index; AN 87-084125, XP002001117, "dna synthetase composition option temperature degree contain dna synthetase polyethylene glycol one mono di valence cation poly amine"

Download PDF:

View/Download PDF PDF Help

Previous Patent: CLONED TRANSCRIPTION FACTOR REGULATING MHC EXPRESSION

Next Patent: METHOD FOR HEAP BIOOXIDATION OF ORE